American Medical Association Debates Informed Prescribing
When the American Medical Association gathers this weekend in Dallas, the House of Delegates will consider a resolution with real-world implications for how much – and what sort – of information physicians can access about the medications they prescribe.
FDA Hearings Invite Debate on Abuse-deterrent Pain Pills
Just weeks ago, the Food and Drug Administration approved a third opioid analgesic pain pill designed to frustrate attempts at abuse.
Interactive Tools Prep Patients for Open Enrollment
Just weeks shy of open enrollment for the federal health care exchange, a new initiative from PhRMA seeks to educate patients on how to get optimal coverage.
New AfPA Video Highlights RSV Risks for Unprotected Preemies
RSV, or respiratory syncytial virus, season begins November 1 in most states.
Curing Hepatitis C: A High-cost, High-value Proposition
A promising new class of therapies could reduce hepatitis C, now rampant, to a rare disease in the coming years.
Technology Fixes Don’t Solve ObamaCare’s Access Problem
Earlier this month, HHS announced major improvements to HealthCare.gov, marred since last fall’s open enrollment by website glitches, extensive wait times and cyber hackers.
The Synchronization Solution
Straying from the doctor’s orders can undermine a patient’s health – and result in unnecessary medical expenses.
Transparency Tops Patient Advocates’ Demands at Health Summit
“If you develop the most innovative products in the world, it doesn’t do the patients any good if they can’t access them.”
Leading Patient Advocate Defines “Paying for Value”
Patient-centered health care has garnered enthusiasm across the policy, industry and health care spectrums.
Neurology Academy’s Opioids Stance Renews Access Debate
A new position paper by the American Academy of Neurology has incited renewed debate on opioid analgesics.
